The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence

David Schörghofer, Katharina Kinslechner, Andrea Preitschopf, Birgit Schütz, Clemens Röhrl, Markus Hengstschläger, Herbert Stangl, Mario Mikula

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

Fingerprint

Untersuchen Sie die Forschungsthemen von „The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence“. Zusammen bilden sie einen einzigartigen Fingerprint.

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology